Your browser doesn't support javascript.
loading
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.
Perini, Guilherme Fleury; Fischer, Thais; Gaiolla, Rafael Dezen; Rocha, Talita Bueno; Bellesso, Marcelo; Teixeira, Larissa Lane Cardoso; Delamain, Marcia Torresan; Scheliga, Adriana Alves de Souza; Ribeiro, Glaciano Nogueira; Neto, Jorge Vaz; Baiocchi, Otávio Cesar Carvalho Guimaraes; Abdo, André Neder Ramires; Arrais-Rodrigues, Celso; Fogliatto, Laura M; Bigni, Ricardo de Sá; Schaffel, Rony; Biasoli, Irene; Pereira, Juliana; Nabhan, Samir Kanaan; Souza, Cármino Antônio de; Chiattone, Carlos Sérgio.
  • Perini GF; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Américas Oncologia, São Paulo, SP, Brazil. Electronic address: guilherme.perini@einstein.br.
  • Fischer T; AC Camargo Cancer Center, São Paulo, SP, Brazil.
  • Gaiolla RD; Hospital das Clínicas da Faculdade de Medicina de Botucatu (HC-FMB), São Paulo, SP, Brazil.
  • Rocha TB; AC Camargo Cancer Center, São Paulo, SP, Brazil.
  • Bellesso M; Instituto do Cancer de São Paulo, (ICESP), São Paulo, SP, Brazil; Hemomed, São Paulo, SP, Brazil.
  • Teixeira LLC; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Hospital Municipal da Vila Santa Catarina, São Paulo, SP, Brazil.
  • Delamain MT; Américas Oncologia, São Paulo, SP, Brazil; Universidade de Campinas (UNICAMP), Campinas, SP, Brazil.
  • Scheliga AAS; Grupo Oncoclínicas - CTO/CEON, Rio de Janeiro, RJ, Brazil.
  • Ribeiro GN; Hospital das Clínicas da Universidade Federal de Minas Gerais (HC UFMG), Belo Horizonte, MG, Brazil.
  • Neto JV; Centro de Cancer de Brasilia CETTRO, Brasilia, DF, Brazil.
  • Baiocchi OCCG; Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
  • Abdo ANR; Instituto do Cancer de São Paulo, (ICESP), São Paulo, SP, Brazil; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
  • Arrais-Rodrigues C; Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil; Hospital Sírio Libanês, São Paulo, SP, Brazil.
  • Fogliatto LM; Hospital de Clínicas de Porto Alegre (HPCA), Porto Alegre, RS, Brazil.
  • Bigni RS; Instituto Nacional do Cancer (INCA), Rio de Janeiro, RJ, Brazil.
  • Schaffel R; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Biasoli I; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Pereira J; Instituto do Cancer de São Paulo, (ICESP), São Paulo, SP, Brazil.
  • Nabhan SK; Universidade Federal do Paraná (UFPR), Paraná, PR, Brazil.
  • Souza CA; Universidade de Campinas (UNICAMP), Campinas, SP, Brazil.
  • Chiattone CS; FCM da Santa Casa de São Paulo, São Paulo, SP, Brazil; Hospital Samaritano Higienópolis, São Paulo, SP, Brazil.
Hematol Transfus Cell Ther ; 42(2): 103-110, 2020.
Article en En | MEDLINE | ID: mdl-32313873
ABSTRACT
The novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for severe disease, including a higher risk of intensive care unit (ICU) admission, need for invasive ventilation or death. Management of patients with lymphoid malignancies can be challenging during the outbreak, due to need of multiple hospital visits and admissions, immunosuppression and need for chemotherapy, radiotherapy and stem cell transplantation. In this article, we will focus on the practical management of patients with lymphoid malignancies during the COVID-19 pandemic, focusing on minimizing the risk for patients.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE País como asunto: America do sul / Brasil Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE País como asunto: America do sul / Brasil Idioma: En Año: 2020 Tipo del documento: Article